Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic and Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain;
Pathology Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy; and.
Blood. 2015 Apr 2;125(14):2239-44. doi: 10.1182/blood-2014-11-609883. Epub 2015 Jan 30.
Accurate diagnosis of systemic amyloidosis is necessary both for assessing the prognosis and for delineating the appropriate treatment. It is based on histologic evidence of amyloid deposits and characterization of the amyloidogenic protein. We prospectively evaluated the diagnostic performance of immunoelectron microscopy (IEM) of abdominal fat aspirates from 745 consecutive patients with suspected systemic amyloidoses. All cases were extensively investigated with clinical and laboratory data, with a follow-up of at least 18 months. The 423 (56.8%) cases with confirmed systemic forms were used to estimate the diagnostic performance of IEM. Compared with Congo-red-based light microscopy, IEM was equally sensitive (75% to 80%) but significantly more specific (100% vs 80%; P < .001). In amyloid light-chain (AL) amyloidosis, κ cases were more difficult to diagnose (sensitivity 71%), whereas the analysis of abdominal aspirate was informative in only 40% of patients with transthyretin amyloidosis. We found a high prevalence (20%) of a monoclonal component in patients with non-AL amyloidosis, highlighting the risk of misdiagnosis and the need for unequivocal amyloid typing. Notably, IEM identified correctly the specific form of amyloidosis in >99% of the cases. IEM of abdominal fat aspirates is an effective tool in the routine diagnosis of systemic amyloidoses.
准确诊断系统性淀粉样变性对于评估预后和确定适当的治疗方案都非常必要。它基于淀粉样沉积物的组织学证据和淀粉样蛋白的特征化。我们前瞻性地评估了 745 例疑似系统性淀粉样变患者的腹部脂肪抽吸物免疫电子显微镜(IEM)的诊断性能。所有病例均通过临床和实验室数据进行了广泛调查,并进行了至少 18 个月的随访。用 423 例(56.8%)确诊的系统性淀粉样变病例来评估 IEM 的诊断性能。与刚果红基础的光学显微镜相比,IEM 的敏感性相当(75%~80%),但特异性显著更高(100%对 80%;P<0.001)。在轻链淀粉样(AL)淀粉样变性中,κ 型病例更难诊断(敏感性 71%),而转甲状腺素淀粉样变性患者中只有 40%的腹部抽吸物分析有信息。我们发现非 AL 淀粉样变性患者中有很高的单克隆成分患病率(20%),突出了误诊的风险和明确淀粉样蛋白分型的必要性。值得注意的是,IEM 正确识别了>99%的病例的特定淀粉样变性类型。腹部脂肪抽吸物的 IEM 是常规诊断系统性淀粉样变的有效工具。